Status:
COMPLETED
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
Lead Sponsor:
Medtronic Vascular
Conditions:
Kidney Failure, Chronic
Renal Dialysis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.
Eligibility Criteria
Inclusion
- Systolic blood pressure of 160 mmHg or greater
- On 3 or more antihypertensive medications
- On dialysis for more than 6 months
Exclusion
- Renal artery abnormalities
- Known secondary hypertension attributable to a cause other than sleep apnea
- MI, angina, CVA within 6 months
- Others
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00753116
Start Date
September 1 2008
End Date
December 1 2009
Last Update
November 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hennepin County Medical Center
Minneapolis, Minnesota, United States, 55415